Panacea Life Sciences Holdings, Inc. (PLSH) Net margin 2014–2023
Panacea Life Sciences Holdings, Inc. (PLSH) net profit margin by fiscal year — reported net income divided by reported revenue.
-336.1%FY2023 · since FY2014: -34808.8% → -336.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -336.1% | +225.9 pp |
| FY2022 | -561.9% | -329.7 pp |
| FY2021 | -232.2% | -174.2 pp |
| FY2020 | -58.0% | +2840.3 pp |
| FY2019 | -2898.3% | — |
| FY2015 | -168064.3% | -133255.5 pp |
| FY2014 | -34808.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice